United States · FDA National Drug Code directory
Lacosamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-2024_80024eb8-f6ab-420a-94df-dc5dd9ffb9b3
- Product NDC
- 0121-2024
- Form
- SOLUTION
- Composition / generic term
- Lacosamide
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220826
- Source listing expiry
- 20261231
Source-listed ingredients
- LACOSAMIDE — 100 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TRAY in 1 TRAY (0121-2024-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-2024-10) · 0121-2024-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →